SkinHealth Systems (SKIN) Net Income towards Common Stockholders (2020 - 2026)

SkinHealth Systems (SKIN) has reported Net Income towards Common Stockholders for 7 consecutive years, with -$2.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 113.54% year-over-year to -$2.7 million in Q2 2026; TTM through Jun 2026 was -$28.4 million, a 49.52% decrease from a year earlier, with the FY2025 full-year figure at -$9.5 million, up 67.29% from the prior year.
• Net Income towards Common Stockholders was -$2.7 million for Q2 2026 at SkinHealth Systems, up from -$6.6 million in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $31.5 million in Q1 2022 and troughed at -$73.8 million in Q3 2023.
• A 5-year average of -$5.8 million and a median of -$4.6 million in 2026 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders tumbled 91059.26% in 2023 and jumped 7819.28% in 2025, its largest moves.
• Over 5 years, Net Income towards Common Stockholders stood at $6.6 million in 2022, then tumbled by 243.64% to -$9.4 million in 2023, then dropped by 9.58% to -$10.3 million in 2024, then increased by 21.69% to -$8.1 million in 2025, then surged by 67.0% to -$2.7 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$2.7 million (Q2 2026), -$6.6 million (Q1 2026), and -$8.1 million (Q4 2025), per Business Quant data.